Background

High-molecular-weight kininogen (HK) is a major component of plasma kallikrein-kinin system (KKS). Upon activation of the KKS, the cleavage products of HK, bradykinin and HKa are produced. The in vitro studies have shown that both bradykinin and HKa are proinflammatory. Clinical observations have indicated that the activation of KKS and HK cleavage exists in patients with inflammatory bowel disease (IBD). However, the role of HK in the pathogenesis of IBD has never been characterized using a genetic approach.

Methods

We characterized the role of HK and bradykinin in the pathogenesis of IBD and the underlying mechanisms using HK-deficient (Kng1−/−) and bradykinin receptor deficient mice, in a dextran sulfate sodium (DSS)-induced colitis model. Mice were treated with 2.5% (wt/vol) DSS in drinking water for 7 days.

Results

Plasma level of bradykinin in wild-type (WT) mice was elevated on day 7 in DSS-induced colitis (P < 0.001), suggesting the activation of the KKS in this model. Weight loss index and disease activity index (DAI) of DSS-treated HK-deficient (Kng1−/−) mice were significantly lower than those of WT mice (P < 0.05). As detected by H&E staining, colonic tissue damage in Kng1−/− mice was ameliorated compared with that of WT mice. Moreover, Kng1−/− mice exhibited a decrease in colonic cytokines (TNF-α, IL-1β, IL-6, INF-γ) and myeloperoxidase (MPO) level (P < 0.001). Neutrophil infiltration in colonic lamina propria was also reduced in Kng1−/− mice (P < 0.001). Furthermore, the mice lacking double bradykinin receptors (B1RB2R−/−) also exhibited a reduced DSS-induced colitis, including amelioration of weight loss, DAI, colonic tissue damage, and colonic cytokine levels.

Conclusions

Our results demonstrate that HK and its cleavage product bradykinin play a critical role in the pathogenesis of IBD.

This content is only available as a PDF.
You do not currently have access to this article.